Free Trial

Kenneth D. Krause Sells 5,000 Shares of Rollins, Inc. (NYSE:ROL) Stock

Rollins, Inc. (NYSE:ROL - Get Free Report) CFO Kenneth D. Krause sold 5,000 shares of the stock in a transaction that occurred on Friday, April 26th. The stock was sold at an average price of $45.00, for a total value of $225,000.00. Following the completion of the transaction, the chief financial officer now owns 94,078 shares in the company, valued at approximately $4,233,510. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Rollins Stock Performance

Shares of ROL traded down $0.13 during mid-day trading on Monday, hitting $44.77. The company's stock had a trading volume of 1,233,172 shares, compared to its average volume of 1,949,550. Rollins, Inc. has a one year low of $32.19 and a one year high of $47.45. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.66 and a current ratio of 0.72. The firm has a market capitalization of $21.68 billion, a PE ratio of 50.30, a price-to-earnings-growth ratio of 3.51 and a beta of 0.63. The stock's 50-day moving average is $44.61 and its two-hundred day moving average is $42.26.

Rollins (NYSE:ROL - Get Free Report) last posted its quarterly earnings data on Wednesday, April 24th. The business services provider reported $0.20 earnings per share for the quarter, meeting the consensus estimate of $0.20. Rollins had a return on equity of 37.73% and a net margin of 13.94%. The company had revenue of $748.35 million during the quarter, compared to analysts' expectations of $739.12 million. During the same period in the prior year, the business earned $0.18 earnings per share. Rollins's revenue for the quarter was up 13.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Rollins, Inc. will post 1 EPS for the current year.


Rollins Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, June 10th. Investors of record on Friday, May 10th will be given a $0.15 dividend. The ex-dividend date of this dividend is Thursday, May 9th. This represents a $0.60 annualized dividend and a yield of 1.34%. Rollins's dividend payout ratio (DPR) is currently 67.42%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Czech National Bank lifted its position in Rollins by 0.5% in the first quarter. Czech National Bank now owns 49,396 shares of the business services provider's stock worth $2,286,000 after purchasing an additional 226 shares during the period. Lindbrook Capital LLC raised its stake in Rollins by 72.4% during the fourth quarter. Lindbrook Capital LLC now owns 619 shares of the business services provider's stock worth $27,000 after acquiring an additional 260 shares in the last quarter. Avantax Advisory Services Inc. raised its stake in Rollins by 3.8% during the third quarter. Avantax Advisory Services Inc. now owns 7,150 shares of the business services provider's stock worth $267,000 after acquiring an additional 263 shares in the last quarter. Benjamin F. Edwards & Company Inc. raised its stake in Rollins by 3.9% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 8,204 shares of the business services provider's stock worth $380,000 after acquiring an additional 306 shares in the last quarter. Finally, Beacon Pointe Advisors LLC raised its stake in Rollins by 4.7% during the fourth quarter. Beacon Pointe Advisors LLC now owns 7,806 shares of the business services provider's stock worth $341,000 after acquiring an additional 348 shares in the last quarter. 51.79% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts recently commented on ROL shares. UBS Group restated a "neutral" rating and issued a $49.00 price objective on shares of Rollins in a report on Monday, April 15th. Royal Bank of Canada reiterated an "outperform" rating and set a $52.00 price target on shares of Rollins in a report on Thursday, February 15th. StockNews.com downgraded Rollins from a "buy" rating to a "hold" rating in a report on Thursday. Morgan Stanley increased their price target on Rollins from $42.00 to $43.00 and gave the company an "equal weight" rating in a report on Friday. Finally, The Goldman Sachs Group initiated coverage on Rollins in a report on Tuesday, January 2nd. They set a "buy" rating and a $49.00 price target on the stock. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, Rollins has an average rating of "Moderate Buy" and an average price target of $47.00.

View Our Latest Stock Analysis on ROL

About Rollins

(Get Free Report)

Rollins, Inc, through its subsidiaries, provides pest and wildlife control services to residential and commercial customers in the United States and internationally. The company offers pest control services to residential properties protecting from common pests, including rodents, insects, and wildlife.

Recommended Stories

Insider Buying and Selling by Quarter for Rollins (NYSE:ROL)

Should you invest $1,000 in Rollins right now?

Before you consider Rollins, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rollins wasn't on the list.

While Rollins currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Featured Articles and Offers

Biotech Boom: Stocks Skyrocketing & What's Next

Biotech Boom: Stocks Skyrocketing & What's Next

Dive into biotech's latest trends with Dylan Jovine: weight loss breakthroughs, smart chemo innovations, and expert stock evaluation tips.

Search Headlines: